Key Players' Offerings in the Dental Regeneration Market
See the full picture of the Dental Regeneration Market without the complexity - Download Free Sample.
| Company | Description |
| Bioteck S.p.A. | This offers diverse regenerative solutions for dentistry, mainly based on their proprietary Zymo-Teck enzymatic deantigenation process. |
| Dentsply Sirona | This primarily facilitates the OSSIX product family & the Symbios allograft line. |
| Maxigen Biotech Inc. | Its offerings include collagen-based and synthetic biomaterials to support soft & hard tissue repair. |
| Institut Straumann AG | A firm provides a comprehensive portfolio for dental regeneration, specializes in periodontal regeneration, bone grafting, & soft tissue management. |
| Nobel Biocare Services AG (Envista) | This majorly offers creos xenogain (bone substitute), creos xenoprotect (collagen membrane), & synthetic alternatives to assist Guided Bone (GBR) & Tissue Regeneration (GTR). |
| Geistlich Holding | A company focuses on providing products for guided bone regeneration (GBR), sinus floor elevation, & periodontal treatment. |
| ZimVie Inc. | They have explored Puros Allografts, RegenerOss Xenografts, & advanced barrier membranes. |
| NovaBone | Its portfolio facilitates bioactive synthetic bone graft substitutes. |
| Osteogenics Biomedical | This usually offers non-resorbable PTFE membranes, collagen membranes, allografts, soft tissue products, & fixation systems. |
| Regenity | A firm specializes in bioresorbable and biocompatible products for dental regeneration. |
What are the Revolutionary Developments in the Dental Regeneration Market?
- In February 2026, Zahn Dental rolled out the Zirlux Independence ML, a multi-layered zirconia disc to meet dental laboratories’ growing demands for strength, superior aesthetics, & effectiveness.
- In February 2025, LifeNet Health launched OraGen, the foremost viable dental bone allograft consisting of cryopreserved corticocancellous bone with endogenous lineage-committed bone cells integrated with demineralized bone matrix.
- In September 2024, Regenity Biosciences received regulatory approval from the NMPA of China for its new crosslinked bioresorbable, implantable collagen dental membrane intended for use in oral surgical procedures.
Dental Regeneration Market- Supply Chain Analysis
R&D
- Leaders are following reconstruction of hard and soft tissues, mainly the enamel, dentin, pulp-dentin complex, & periodontal tissues by employing tissue engineering principles.
- Key Players: Toregem Biopharma, Geistlich Pharma, Straumann Group, etc.
Clinical Trials & Regulatory Approvals
- Trials are approaching safety study in adults, efficacy studies, & eventual application for children with missing teeth, with emphasis on either drug-induced tooth regrowth or stem cell-based tissue engineering to regenerate dental pulp & enamel.
- Key Players: University of Turin, Italy, Universidad de los Andes, Chile, University of Pisa, etc.
Patient Support & Services
- This primarily covers dental pulp regeneration, periodontal tissue regeneration, & in experimental stages, whole-tooth replacement.
- Key Players: Dentsply Sirona, Botiss Biomaterials GmbH, Regedent AG, etc.
Market Growth
The global dental regeneration market size was estimated at USD 6.85 billion in 2025 and is predicted to increase from USD 7.52 billion in 2026 to approximately USD 17.45 billion by 2035, expanding at a CAGR of 9.8% from 2026 to 2035. A substantial rise in tooth loss & periodontal disease cases is driving the need for advanced dental regeneration approaches. For this, notable efforts called bioprinting, stem cell therapies, and rigorous hybrid materials are fostering the overall market progression.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking